Drug shortages homepage
Welcome to Drug Shortages Canada, the website for reporting drug shortages and discontinuations in Canada. The Food and Drug Regulations require drug sellers to report when they are not able to meet demand for a product or when they stop selling a product. Information about the website and the regulations can be found on the About & Resources Page.
A shortage means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug is unable to meet the demand for the drug.
Below are the newest and most recently updated Shortage and Discontinuation reports.
Shortage Reports
| Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
|---|---|---|---|---|---|---|
| SANDOZ GLICLAZIDE MR | SANDOZ CANADA INCORPORATED | Actual shortage | 60MG | New Report | 2020-04-06 | 111112 |
| SANDOZ FAMCICLOVIR | SANDOZ CANADA INCORPORATED | Actual shortage | 250MG | Updated Report | 2020-04-06 | 109946 |
| SANDOZ DONEPEZIL | SANDOZ CANADA INCORPORATED | Actual shortage | 10MG | Updated Report | 2020-04-06 | 109935 |
| SANDOZ DILTIAZEM CD | SANDOZ CANADA INCORPORATED | Actual shortage | 120MG | Updated Report | 2020-04-06 | 59502 |
| SANDOZ DICLOFENAC RAPIDE | SANDOZ CANADA INCORPORATED | Actual shortage | 50MG | New Report | 2020-04-06 | 111103 |
| SANDOZ CANDESARTAN | SANDOZ CANADA INCORPORATED | Actual shortage | 8MG | Updated Report | 2020-04-06 | 79529 |
| SANDOZ CANDESARTAN | SANDOZ CANADA INCORPORATED | Actual shortage | 8MG | Updated Report | 2020-04-06 | 79532 |
| SANDOZ CANDESARTAN | SANDOZ CANADA INCORPORATED | Actual shortage | 8MG | Updated Report | 2020-04-06 | 70464 |
| AZITHROMYCIN FOR INJECTION USP | STERIMAX INC | Actual shortage | 500MG | Updated Report | 2020-04-06 | 111093 |
| ETHACRYNATE SODIUM FOR INJECTION USP | STERIMAX INC | Actual shortage | 50MG | Updated Report | 2020-04-06 | 94977 |
| ASMANEX TWISTHALER | MERCK CANADA INC | Actual shortage | 200MCG | Updated Report | 2020-04-06 | 108618 |
| FRAXIPARINE | ASPEN PHARMACARE CANADA INC. | Anticipated shortage | 9500UNIT | New Report | 2020-04-06 | 111066 |
| APO-NALTREXONE | APOTEX INC | Anticipated shortage | 50MG | Updated Report | 2020-04-06 | 111060 |
| PROSCAR | MERCK CANADA INC | Actual shortage | 5MG | Updated Report | 2020-04-06 | 102400 |
| ZOCOR | MERCK CANADA INC | Actual shortage | 10MG | Updated Report | 2020-04-06 | 109064 |
| ELTROXIN | ASPEN PHARMACARE CANADA INC. | Resolved | 100MCG | Updated Report | 2020-04-06 | 110177 |
| ELTROXIN | ASPEN PHARMACARE CANADA INC. | Anticipated shortage | 50MCG | New Report | 2020-04-06 | 111051 |
| APO-ADEFOVIR | APOTEX INC | Actual shortage | 10MG | Updated Report | 2020-04-06 | 104703 |
| EXTRA STRENGTH IBUPROFEN LIQUID GEL CAPSULES | APOTEX INC | Actual shortage | 400MG | Updated Report | 2020-04-06 | 91498 |
| DOPAMINE HCL 0.8MG/ML DEXTROSE 5% INJ USP | BAXTER CORPORATION | Anticipated shortage | .8MG 50MG | Updated Report | 2020-04-06 | 111045 |
| ZOCOR | MERCK CANADA INC | Anticipated shortage | 20MG | New Report | 2020-04-06 | 111042 |
| SANDOZ LOSARTAN HCT | SANDOZ CANADA INCORPORATED | Actual shortage | 12.5MG 100MG | Updated Report | 2020-04-06 | 73152 |
| SANDOZ LOSARTAN HCT | SANDOZ CANADA INCORPORATED | Actual shortage | 12.5MG 100MG | Updated Report | 2020-04-06 | 73155 |
| EURO D 10 000 | SANDOZ CANADA INCORPORATED | Actual shortage | 10000UNIT | New Report | 2020-04-06 | 111034 |
| SANDOZ CYCLOSPORINE | SANDOZ CANADA INCORPORATED | Actual shortage | 50MG | New Report | 2020-04-06 | 111031 |
| SANDOZ CANDESARTAN | SANDOZ CANADA INCORPORATED | Actual shortage | 4MG | Updated Report | 2020-04-06 | 70461 |
| SANDOZ CANDESARTAN | SANDOZ CANADA INCORPORATED | Actual shortage | 4MG | Updated Report | 2020-04-06 | 79524 |
| SANDOZ CANDESARTAN | SANDOZ CANADA INCORPORATED | Actual shortage | 32MG | Updated Report | 2020-04-06 | 79519 |
| SANDOZ CANDESARTAN | SANDOZ CANADA INCORPORATED | Actual shortage | 16MG | Updated Report | 2020-04-06 | 79513 |
| SANDOZ CANDESARTAN | SANDOZ CANADA INCORPORATED | Actual shortage | 16MG | Updated Report | 2020-04-06 | 79516 |
| SANDOZ CANDESARTAN | SANDOZ CANADA INCORPORATED | Actual shortage | 16MG | Updated Report | 2020-04-06 | 73116 |
| SANDOZ CANDESARTAN PLUS | SANDOZ CANADA INCORPORATED | Actual shortage | 25MG 32MG | Updated Report | 2020-04-06 | 75449 |
| APO-SIMVASTATIN | APOTEX INC | Resolved | 80MG | Updated Report | 2020-04-06 | 99795 |
| SANDOZ CANDESARTAN PLUS | SANDOZ CANADA INCORPORATED | Actual shortage | 12.5MG 32MG | Updated Report | 2020-04-06 | 76110 |
| SANDOZ CANDESARTAN PLUS | SANDOZ CANADA INCORPORATED | Actual shortage | 12.5MG 16MG | Updated Report | 2020-04-06 | 73126 |
| SANDOZ AMPHETAMINE XR | SANDOZ CANADA INCORPORATED | Actual shortage | 30MG | Updated Report | 2020-04-06 | 108901 |
| ERYTHRO-BASE | AA PHARMA INC | Anticipated shortage | 250MG | New Report | 2020-04-06 | 111006 |
| BROMOCRIPTINE | AA PHARMA INC | Anticipated shortage | 2.5MG | Updated Report | 2020-04-06 | 111002 |
| BRIMONIDINE P | AA PHARMA INC | Actual shortage | 0.15% | Updated Report | 2020-04-06 | 75649 |
| BRIMONIDINE P | AA PHARMA INC | Actual shortage | 0.15% | Updated Report | 2020-04-06 | 75644 |
| APO-HYDROMORPHONE CR | APOTEX INC | Resolved | 9MG | Updated Report | 2020-04-04 | 71127 |
| APO-HYDROMORPHONE CR | APOTEX INC | Resolved | 6MG | Updated Report | 2020-04-04 | 71124 |
| APO-HYDROMORPHONE CR | APOTEX INC | Resolved | 24MG | Updated Report | 2020-04-04 | 79039 |
| APO-HYDROMORPHONE CR | APOTEX INC | Resolved | 3MG | Updated Report | 2020-04-04 | 74019 |
| APO-HYDROMORPHONE CR | APOTEX INC | Resolved | 30MG | Updated Report | 2020-04-04 | 77858 |
| APO-HYDROMORPHONE CR | APOTEX INC | Resolved | 24MG | Updated Report | 2020-04-04 | 77855 |
| APO-HYDROMORPHONE CR | APOTEX INC | Resolved | 18MG | Updated Report | 2020-04-04 | 77852 |
| APO-HYDROMORPHONE CR | APOTEX INC | Resolved | 12MG | Updated Report | 2020-04-04 | 77849 |
| APO-HYDROMORPHONE CR | APOTEX INC | Resolved | 4.5MG | Updated Report | 2020-04-04 | 98562 |
| ONE ALPHA CAPS 1MCG | LEO PHARMA INC | Anticipated shortage | 1MCG | New Report | 2020-04-04 | 110953 |
Discontinuation Reports
| Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
|---|---|---|---|---|---|---|
| M-EZETIMIBE | MANTRA PHARMA INC | To be discontinued | 10MG | New Report | 2020-04-06 | 111090 |
| PMS-RAMIPRIL | PHARMASCIENCE INC | To be discontinued | 10MG | New Report | 2020-04-06 | 111084 |
| PMS-RAMIPRIL | PHARMASCIENCE INC | To be discontinued | 5MG | New Report | 2020-04-06 | 111081 |
| PMS-LISINOPRIL | PHARMASCIENCE INC | To be discontinued | 10MG | New Report | 2020-04-06 | 111078 |
| PMS-CILAZAPRIL | PHARMASCIENCE INC | To be discontinued | 5.0MG | New Report | 2020-04-06 | 111075 |
| PMS-CILAZAPRIL | PHARMASCIENCE INC | To be discontinued | 5.0MG | New Report | 2020-04-06 | 111072 |
| PMS-CILAZAPRIL | PHARMASCIENCE INC | To be discontinued | 2.5MG | New Report | 2020-04-06 | 111069 |
| PMS-CILAZAPRIL | PHARMASCIENCE INC | To be discontinued | 1.0MG | New Report | 2020-04-06 | 111063 |
| APO-HYDROMORPHONE CR | APOTEX INC | Discontinued | 9MG | New Report | 2020-04-04 | 110977 |
| APO-HYDROMORPHONE CR | APOTEX INC | Discontinued | 4.5MG | New Report | 2020-04-04 | 110974 |
